BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36689537)

  • 1. Greater understanding about genetic factors in keloid development.
    Br J Dermatol; 2023 Jan; 188(1):e9. PubMed ID: 36689537
    [No Abstract]   [Full Text] [Related]  

  • 2. Associations between keloid severity and single-nucleotide polymorphisms: importance of rs8032158 as a biomarker of keloid severity.
    Ogawa R; Watanabe A; Than Naing B; Sasaki M; Fujita A; Akaishi S; Hyakusoku H; Shimada T
    J Invest Dermatol; 2014 Jul; 134(7):2041-2043. PubMed ID: 24496234
    [No Abstract]   [Full Text] [Related]  

  • 3. Up-regulation of metallothionein isoforms in keloid keratinocytes.
    Lim D; Phan TT; Yip GW; Bay BH
    Int J Mol Med; 2006 Feb; 17(2):385-9. PubMed ID: 16391841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic characteristics of six Chinese Han keloid pedigrees].
    Chen Y; Gao JH; Liu XJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):976-9. PubMed ID: 17666330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA deregulation in keloids: an opportunity for clinical intervention?
    Yu X; Li Z; Chan MT; Wu WK
    Cell Prolif; 2015 Dec; 48(6):626-30. PubMed ID: 26486103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [p53 gene codon 72 polymorphism and susceptibility to keloid in Chinese population].
    Zhuo Y; Gao J; Luo S; Zeng W; Hu Z; Lu F; Zhao Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Jan; 19(1):28-30. PubMed ID: 15704837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6 Polymorphism and Susceptibility to Keloid Formation in a Japanese Population.
    Tosa M; Watanabe A; Ghazizadeh M
    J Invest Dermatol; 2016 May; 136(5):1069-1072. PubMed ID: 26829033
    [No Abstract]   [Full Text] [Related]  

  • 8. Keloid scars are formed by polyclonal fibroblasts.
    Chevray PM; Manson PN
    Ann Plast Surg; 2004 Jun; 52(6):605-8. PubMed ID: 15166997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiologic changes in a patient with early-onset extensive keloid disease and a 20-year follow-up.
    Steinstraesser L; Sorkin M; Steinau HU; Jacobsen F
    Plast Reconstr Surg; 2010 Nov; 126(5):271e-274e. PubMed ID: 21042090
    [No Abstract]   [Full Text] [Related]  

  • 10. [Establishment of immortalized B-lymphoblastoid cell lines of keloid pedigree and its karyotype analysis].
    Song M; Gao JH; Yan X; Liu XJ; Chen Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1760-2. PubMed ID: 17259115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-21 may be involved in the therapeutic effects of Galla chinensis ointment on keloid.
    Tang Z; Ding J; Zhai X; Jing M; Guan Z; Li Y
    J Int Med Res; 2020 Mar; 48(3):300060520909602. PubMed ID: 32216491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study on apoptosis of keloid-derived fibroblast transducted with Fas gene by recombinant adenovirus].
    Lu F; Gao JH
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2004 Jul; 20(4):268-70. PubMed ID: 15568750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High in situ mRNA levels of IL-22, TFG-β, and ARG-1 in keloid scars.
    da Cunha Colombo Tiveron LR; da Silva IR; da Silva MV; Peixoto AB; Rodrigues DBR; Rodrigues V
    Immunobiology; 2018 Dec; 223(12):812-817. PubMed ID: 30146129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension: a systemic key to understanding local keloid severity.
    Arima J; Huang C; Rosner B; Akaishi S; Ogawa R
    Wound Repair Regen; 2015; 23(2):213-21. PubMed ID: 25728259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression patterns in isolated keloid fibroblasts.
    Satish L; Lyons-Weiler J; Hebda PA; Wells A
    Wound Repair Regen; 2006; 14(4):463-70. PubMed ID: 16939575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keloid disorder: Fibroblast differentiation and gene expression profile in fibrotic skin diseases.
    Macarak EJ; Wermuth PJ; Rosenbloom J; Uitto J
    Exp Dermatol; 2021 Jan; 30(1):132-145. PubMed ID: 33211348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetically altered wound healing in keloid fibroblasts.
    Russell SB; Russell JD; Trupin KM; Gayden AE; Opalenik SR; Nanney LB; Broquist AH; Raju L; Williams SM
    J Invest Dermatol; 2010 Oct; 130(10):2489-96. PubMed ID: 20555348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics and Epigenetics of Keloids.
    Nyika DT; Khumalo NP; Bayat A
    Adv Wound Care (New Rochelle); 2022 Apr; 11(4):192-201. PubMed ID: 34498914
    [No Abstract]   [Full Text] [Related]  

  • 19. Upregulation of HSP47 and collagen type III in the dermal fibrotic disease, keloid.
    Naitoh M; Hosokawa N; Kubota H; Tanaka T; Shirane H; Sawada M; Nishimura Y; Nagata K
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1316-22. PubMed ID: 11162672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HtrA1 Is Specifically Up-Regulated in Active Keloid Lesions and Stimulates Keloid Development.
    Yamawaki S; Naitoh M; Kubota H; Aya R; Katayama Y; Ishiko T; Tamura T; Yoshikawa K; Enoshiri T; Ikeda M; Suzuki S
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.